Helicobacter

雜志介紹

Helicobacter雜志介紹

《Helicobacter》是一本以English為主的未開放獲取國際優秀期刊，中文名稱幽門螺桿菌，本刊主要出版、報道醫學-MICROBIOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4.3，最新CiteScore 指數為8.4。

本刊近期中國學者發表的論文主要有：

• Quantitative PCR of string-test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptibility-guided therapy

  Author: Han, Xinyuan; Yu, Xiqiu; Gao, Xiaojuan; Wang, Xiangyu; Tay, Chin Yen; Wei, Xiaolan; Lai, Bing; Marshall, Barry J.; Zhang, Xiuming; Chua, Eng Guan

• Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial

  Author: Tian, Xue-li; Suo, Bao-jun; Zhang, Hua; Lu, Hao-ping; Li, Cai-ling; Zhang, Yu-xin; Ren, Xin-lu; Yao, Xing-yu; Zhou, Li-ya; Song, Zhi-qiang

• Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection

  Author: Ji, Yan-Hong; Shi, Yan-Mei; Hei, Qian-Wen; Sun, Jin-Min; Yang, Xiao-Feng; Wu, Tao; Sun, Da-Li; Qi, Yu-Xing

• Discussion on the common controversies of Helicobacter pylori infection

  Author: Yang, Hang; Mou, Yi; Hu, Bing

英文介紹

Helicobacter雜志英文介紹

Helicobacter is edited by Professor David Y Graham. The editorial and peer review process is an independent process. Whenever there is a conflict of interest, the editor and editorial board will declare their interests and affiliations. Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of gastroenterology; microbiology; vaccine development; laboratory animal science.